253 related articles for article (PubMed ID: 21071579)
1. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.
Chen Y; Zaman MS; Deng G; Majid S; Saini S; Liu J; Tanaka Y; Dahiya R
Cancer Prev Res (Phila); 2011 Jan; 4(1):76-86. PubMed ID: 21071579
[TBL] [Abstract][Full Text] [Related]
2. Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221.
Li Y; Liu M; Zhang Y; Han C; You J; Yang J; Cao C; Jiao S
Tumour Biol; 2013 Dec; 34(6):3545-54. PubMed ID: 23801152
[TBL] [Abstract][Full Text] [Related]
3. Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.
Hirata H; Hinoda Y; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Dahiya R
Br J Cancer; 2014 Mar; 110(6):1645-54. PubMed ID: 24504368
[TBL] [Abstract][Full Text] [Related]
4. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
5. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
6. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
[TBL] [Abstract][Full Text] [Related]
7. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
[TBL] [Abstract][Full Text] [Related]
9. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of ARHI decreases tumor growth, migration, and invasion in human glioma.
Chen J; Shi S; Yang W; Chen C
Med Oncol; 2014 Mar; 31(3):846. PubMed ID: 24458808
[TBL] [Abstract][Full Text] [Related]
11. The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate cancer.
Lin D; Cui F; Bu Q; Yan C
J Int Med Res; 2011; 39(5):1870-5. PubMed ID: 22117988
[TBL] [Abstract][Full Text] [Related]
12. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
[TBL] [Abstract][Full Text] [Related]
14. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.
Majid S; Dar AA; Saini S; Chen Y; Shahryari V; Liu J; Zaman MS; Hirata H; Yamamura S; Ueno K; Tanaka Y; Dahiya R
Cancer Res; 2010 Apr; 70(7):2809-18. PubMed ID: 20332239
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
Kong Q; Chen XS; Tian T; Xia XY; Xu P
Oncol Rep; 2017 Feb; 37(2):803-812. PubMed ID: 27959429
[TBL] [Abstract][Full Text] [Related]
16. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.
Chiyomaru T; Yamamura S; Zaman MS; Majid S; Deng G; Shahryari V; Saini S; Hirata H; Ueno K; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Nakagawa M; Dahiya R
PLoS One; 2012; 7(8):e43812. PubMed ID: 22928040
[TBL] [Abstract][Full Text] [Related]
17. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
Kikuno N; Shiina H; Urakami S; Kawamoto K; Hirata H; Tanaka Y; Majid S; Igawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):552-60. PubMed ID: 18431742
[TBL] [Abstract][Full Text] [Related]
18. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.
Wang H; Liu W; Black S; Turner O; Daniel JM; Dean-Colomb W; He QP; Davis M; Yates C
Oncotarget; 2016 Feb; 7(5):5677-89. PubMed ID: 26734997
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
